CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −12,692 | $39.14 | $497K | 200,624 |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −12,477 | $40.29 | $503K | 188,147 |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −4,231 | $40.88 | $173K | 183,916 |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sale 10b5-1 | −600 | $41.77 | $25K | 183,316 |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 58,614 | ||
| 2026-03-25 | PERLROTH VICTOR Chairman and CEO | Option exercise | +300,000 | $1.04 | $312K | 2,395,538 |
| 2026-03-25 | PERLROTH VICTOR Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2026-03-18 | PERLROTH VICTOR Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2025-12-18 | BAKER BROS. ADVISORS LP Director | Purchase | +217,428 | $23.00 | $5.0M | 1,560,414 |
| 2025-12-18 | BAKER BROS. ADVISORS LP Director | Purchase | +2,391,268 | $23.00 | $55.0M | 18,358,772 |
| 2025-07-04 | BORGESON JOHN A. See Remarks | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2025-07-04 | PERLROTH VICTOR Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +340,000 | 340,000 | ||
| 2025-06-30 | PROFUSEK ROBERT Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-30 | Yang Taiyin Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-30 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-30 | Bancroft Charles A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-30 | Dahiyat Bassil I Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Options (right to buy) | +40,000 | 40,000 | ||
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Options (right to buy) | +40,000 | 40,000 | ||
| 2025-06-17 | BORGESON JOHN A. See Remarks | Sale | −723 | $3.65 | $3K | 183,316 |
Page 7 of 20 · 388 trades